NDC 59676-040-28
BALVERSA 4 mg/1
Erdafitinib · TABLET, FILM COATED
Balversa (erdafitinib) is an oral tablet used to treat certain types of bladder cancer that have specific genetic mutations in fibroblast growth factor receptors. It works by blocking kinase enzymes that help cancer cells grow and divide.
Key Facts
- Brand Name
- BALVERSA
- Generic Name
- Erdafitinib
- NDC Code (Package)
59676-040-28- NDC Code (Product)
59676-040- Manufacturer
- Janssen Products LP
- Strength
- 4 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA212018
- Drug Class
- Kinase Inhibitor [EPC]
- Marketing Start
- 04/12/2019
Recall History
No Recall HistoryView Full Drug Page
BALVERSA — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.